BICYCLE THERAPEUTICS PLC
B900, Babraham Research Campus
Cambridge CB22 3AT
United Kingdom
June 11, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey Gabor
RE: Bicycle Therapeutics plc
Registration Statement on Form S-3
File No. 333-238996
Acceleration Request
Requested Date: June 15, 2020
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-238996) (the Registration Statement) to become effective at 4:00 p.m. Eastern Time on Monday, June 15, 2020, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Jaime L. Chase of Cooley LLP, counsel to the registrant, at (202) 728-7096.
[Signature page follows]
Sincerely,
BICYCLE THERAPEUTICS PLC |
| |
|
| |
|
| |
By: |
/s/ Lee Kalowski |
|
|
Lee Kalowski |
|
|
Chief Financial Officer and President |
|
|
|
|
|
|
|
cc: |
Kevin Lee, Chief Executive Officer, Bicycle Therapeutics plc | |
|
Laura A. Berezin, Cooley LLP |
|
|
Ryan S. Sansom, Cooley LLP |
|
|
Jaime L. Chase, Cooley LLP |
|